Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Jun 15, 2025; 17(6): 107364
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.107364
Table 2 Risk of hepatocellular carcinoma by abdominal obesity and body mass index
Characteristics
BMI (kg/m2)
n
Event (n)
Person-years
Incidence rate
Hazard ratio (95%CI)
P for interaction
No abdominal obesity< 18.582815713921.01.77 (1.06-2.96)0.012
18.5-22.9863056168547257.21 (reference)-
23-24.921217982521495593.80.65 (0.59-0.73)-
25-29.929540386730120252.90.62 (0.56-0.69)-
≥ 30763627777803.51.15 (0.78-1.69)-
Abdominal obesity< 18.553245743.85.89 (1.43-24.2)-
18.5-22.9657550612358.21 (reference)-
23-24.9483802974747376.30.92 (0.68-1.24)-
25-29.9353051165135554054.60.99 (0.75-1.32)-
≥ 3010036342310181344.21.43 (1.06-1.94)-